Recent Advances of Taxol-Loaded Biocompatible Nanocarriers Embedded in Natural Polymer-Based Hydrogels
Open Access
Abstract
The discovery of paclitaxel (PTX) has been a milestone in anti-cancer therapy and has promoted the development and marketing of various formulations that have revolutionized the therapeutic approach towards several malignancies. Despite its peculiar anti-cancer activity, the physico-chemical properties of PTX compromise the administration of the compound in polar media. Because of this, since the development of the first Food and Drug Administration (FDA)-approved formulation (Taxol®), consistent efforts have been made to obtain suitable delivery systems able to preserve/increase PTX efficacy and to overcome the side effects correlated to the presence of some excipients. The exploitation of natural polymers as potential materials for drug delivery purposes has favored the modulation of the bioavailability and the pharmacokinetic profiles of the drug, and in this regard, several formulations have been developed that allow the controlled release of the active compound. In this mini-review, the recent advances concerning the design and applications of natural polymer-based hydrogels containing PTX-loaded biocompatible nanocarriers are discussed. The technological features of these formulations as well as the therapeutic outcome achieved following their administration will be described, demonstrating their potential role as innovative systems to be used in anti-tumor therapy.Keywords
This publication has 198 references indexed in Scilit:
- Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulationMolecular Medicine Reports, 2013
- Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumorsJournal of Controlled Release, 2012
- Paclitaxel/Tetrandrine Coloaded Nanoparticles Effectively Promote the Apoptosis of Gastric Cancer Cells Based on “Oxidation Therapy”Molecular Pharmaceutics, 2011
- Global Inhibition of Reactive Oxygen Species (ROS) Inhibits Paclitaxel-Induced Painful Peripheral NeuropathyPLOS ONE, 2011
- Silk fibroin as a vehicle for drug delivery applicationsJournal of Controlled Release, 2011
- Modified Gellan Gum hydrogels with tunable physical and mechanical propertiesBiomaterials, 2010
- Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancerInternational Journal of Nanomedicine, 2009
- Mechanisms of Silk Fibroin Sol−Gel TransitionsThe Journal of Physical Chemistry B, 2006
- Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast CancerJournal of Clinical Oncology, 2005
- Collagen – biomaterial for drug delivery1Dedicated to Professor Dr. Eberhard Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, on the occasion of his 70th birthday.1European Journal of Pharmaceutics and Biopharmaceutics, 1998